Boeing Slips as Kodiak Sciences Jumps in Premarket Trading
A reported 737 MAX software glitch weighed on Boeing, while Kodiak shares surged after the biotech released Phase 3 study results.
Makkler Newsroom · Sep 28, 03:14 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $129.50 (+16.5%)
Prices may be delayed and are for informational purposes only - not investment advice.
A reported 737 MAX software glitch weighed on Boeing, while Kodiak shares surged after the biotech released Phase 3 study results.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.